At knownwell , were committed to making evidence-based, FDA-approved GLP-1 and other FDA approved medications for weight management more accessible to our patients
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature
Second, targeting eryptosis pathways offers new therapeutic opportunities: strategies to mitigate eryptosis could include optimizing clearance of eryptosis-inducing uremic toxins via advanced dialysis modalities (e.g., hemodialysis combined with hemadsorption [HA + HD] for protein-bound uremic toxins) or novel pharmacotherapies, such as inhibitors of Organic Anion Transporter 2 (OAT2) to block indoxyl sulfate uptake by erythrocytes, antioxidants (e.g., N-acetyl-L-cysteine, vitamin E) to counteract oxidative stress-mediated eryptosis, or modulators of Ca 2+ signaling (e.g., NO donors) to stabilize erythrocyte membrane asymmetry
Instead of just targeting one hormone receptor like Wegovy does, Tirzepatide activates two different receptors in your body - GLP-1 (the same one Wegovy targets) and GIP
Historical Background and Scientific Context Scientific interest in glutathione dates back to the early twentieth century following its identification as a naturally occurring intracellular peptide present throughout biological systems
How GLP-1 Drugs Target Both at Once GLP-1 receptor agonists were designed for metabolic purposes: regulating blood sugar, slowing gastric emptying, and reducing appetite